openPR Logo
Press release

Fendory Introduces New Personalized Frozen Merchandise

10-08-2025 09:36 PM CET | Leisure, Entertainment, Miscellaneous

Press release from: ABNewswire

United States - 08 October, 2025 - Fendory, a Print-on-Demand platform for officially licensed merchandise, today launched a new Frozen collection featuring over 90 customizable apparel items. Available globally via Fendory.com, the collection allows fans to personalize Disney-approved designs.

This Frozen [https://fendory.com/collections/frozen-merchandis] launch marks the latest addition to Fendory's expanding lineup of officially licensed Disney products. Created entirely on demand, each item follows Disney's brand-approved guidelines and is printed only after an order is placed. Such an approach reduces waste and ensures full IP compliance, offering a legal and ethical alternative to unlicensed merchandise.

Available products include:

* T-shirts
* Long sleeves
* Hoodies
* Tank tops
* Sweatshirts

All products are available in sizes S to 5XL and feature designs of fan-favorite characters. Newly featured designs include Elsa, Anna, Olaf, and other iconic figures from the Frozen universe.

"Our previous Disney launches proved that fans are actively seeking high-quality, officially licensed merchandise they can trust," said Nguyen Quang Dong, CEO of Fendory. "With Frozen, we're proud to continue promoting licensing transparency, especially in a market saturated with counterfeit Disney goods. Fans deserve products that honor the characters they love."

About Fendory

Established in 2024, Fendory operates a Print-on-Demand platform delivering high-quality, licensed merchandise spanning pop culture, gaming, and sports. Committed to transparent licensing and ethical consumerism, Fendory empowers fans to create meaningful, personalized products without compromise.

Media Contact
Company Name: Fendory
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=fendory-introduces-new-personalized-frozen-merchandise]
Country: United States
Website: https://fendory.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fendory Introduces New Personalized Frozen Merchandise here

News-ID: 4214644 • Views:

More Releases from ABNewswire

Congestive Heart Failure Market Poised for Substantial Growth by 2034: Recent FDA Approvals, Strategic Market Opportunities | DelveInsight
Congestive Heart Failure Market Poised for Substantial Growth by 2034: Recent FD …
The congestive heart failure market is projected to witness substantial growth driven by rising prevalence, technological advancements, and innovative treatment options. Key pharmaceutical companies, including Novartis, Alnylam Pharmaceuticals, Otsuka, AstraZeneca, Bayer, Novo Nordisk, Boehringer Ingelheim, Eli Lilly, Lexicon Pharmaceuticals, Mesoblast, BioCardia, Cytokinetics, and others, are actively developing novel therapies to address significant unmet needs. DelveInsight's "Congestive Heart Failure Market Insights, Epidemiology, and Market Forecast- 2034 [https://www.delveinsight.com/report-store/congestive-heart-failure-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report delivers comprehensive insights into
Hormone Replacement Therapy Market Set to Grow at a Robust CAGR of 6.5% Through 2030, Driven by Rising Menopausal Population and Novel Treatment Approaches | DelveInsight
Hormone Replacement Therapy Market Set to Grow at a Robust CAGR of 6.5% Through …
Key hormone replacement therapy companies include Abbott, Novartis AG, Pfizer Inc., Merck KGaA, Bayer AG, Halozyme Therapeutics, Eli Lilly and Company, Viatris Inc., F. Hoffman-La Roche, Novo Nordisk A/S, Amgen Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Ascendis Pharma, Vista Pharma, Inc., Clarus Therapeutics, Inc., Gedeon Richter Plc, Endo International plc and several others. DelveInsight's "Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast -
Migraine Market Size Projected to Grow Rapidly by 2034: FDA Approvals and Strategic Opportunities | DelveInsight
Migraine Market Size Projected to Grow Rapidly by 2034: FDA Approvals and Strate …
The migraine therapeutics market is experiencing robust growth. Key migraine companies, including Lundbeck Seattle BioPharmaceutical, Eli Lilly and Company, Amgen, Novartis, Teva Pharmaceuticals, Biohaven Pharmaceuticals, Dr. Reddy's Labs, AbbVie, Impel NeuroPharma, Zosano Pharma, Axsome Therapeutics, Aeon Biopharma, Ionis Pharmaceuticals, and Charleston Laboratories, among others, are actively developing next-generation therapies targeting novel mechanisms of action to address the unmet needs. DelveInsight's "Migraine Market Insight, Epidemiology And Market Forecast - 2034 [https://www.delveinsight.com/report-store/migraine-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report
Capsule Endoscopy Market Set to Grow at 9.61% CAGR: Growth Drivers, Strategic Opportunities | DelveInsight
Capsule Endoscopy Market Set to Grow at 9.61% CAGR: Growth Drivers, Strategic Op …
The capsule endoscopy market is experiencing robust growth driven by the increasing prevalence of gastrointestinal disorders, technological advancements in minimally invasive diagnostic procedures, and the rising integration of AI. Major capsule endoscopy manufacturers, including Medtronic, Olympus Corporation, IntroMedic, JINSHAN Science & Technology, FUJIFILM Holdings America Corporation, CapsoVision, and AnX Robotica, are fueling market expansion through enhanced diagnostic capabilities DelveInsight's "Capsule Endoscopy - Market Insights, Competitive Landscape, and Market Forecast - 2030

All 5 Releases


More Releases for Fendory

Fendory Secures Disney Licensing for New On-Demand Apparel Line
United States - 02 October, 2025 - Fendory, the Print-on-Demand platform redefining licensed merchandise, has teamed up with Disney to launch a customizable apparel collection available worldwide starting today. Fans can now legally design and wear their favorite Disney characters, marking a bold step against bootlegs and toward a more creative, ethical fan experience. The collection features iconic characters from beloved Disney franchises. Notable characters include Mickey Mouse, Minnie Mouse, Donald
Fendory Pioneers In Officially Licensed Print-on-Demand Merchandise
PUERTO RICO - 04 August, 2025 - Fendory, a leading online marketplace for officially licensed Print-on-Demand (POD) products, announces licensing agreements with global brands to offer fans and creators access to authentic merchandise in a fair, transparent environment. The move reinforces Fendory's mission to protect creative ownership while giving fans access to unique, officially sanctioned designs. Through these partnerships, Fendory sets out to redefine how merchandise is created, sold, and